SHARE BASED COMPENSATION |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHARE BASED COMPENSATION |
SHARE-BASED COMPENSATION
Restricted Stock Awards. The number of shares and weighted average grant price of restricted stock awards during the three months ended March 31, 2018 were as follows:
The total fair value of shares vested during the three months ended March 31, 2018 and 2017, determined using the closing price on the grant date, was $2.8 million and $4.1 million, respectively.
Stock Options. The Company did not grant any stock options during the three months ended March 31, 2018.
Employee Stock Purchase Plan (“ESPP”). During the three months ended March 31, 2018, the Company issued 63,438 shares under the ESPP. As of March 31, 2018, 273,325 shares remain available for issuance under the ESPP.
Total share-based compensation expense, which includes stock options, restricted stock and the ESPP, was $0.8 million and $1.2 million for the three months ended March 31, 2018 and 2017, respectively.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||